Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
163.8 USD | +0.69% | +0.57% | +5.55% |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
04-29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.55% | 287B | |
+31.92% | 690B | |
+25.63% | 546B | |
-4.61% | 358B | |
+17.58% | 323B | |
+14.28% | 235B | |
+5.49% | 199B | |
-9.82% | 195B | |
+4.37% | 161B | |
-1.67% | 159B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie : BMO Capital Adjusts AbbVie PT to $129 From $127, Maintains Outperform Rating